Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SIDT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MLXIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MELTF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MMP16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DKK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MPPED2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMCES - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TGFB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UCP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GABRB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BHLHE41 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MEF2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AJAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BMP8B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLCCI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DBI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM126B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APBB1IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on